10-Q: Graham Holdings Reports Strong Q3 Earnings Amid Strategic Shifts

Sentiment:

Quarterly Report


Graham Holdings Company announced a significant increase in net income and earnings per share for the third quarter and first nine months of 2025, driven by strategic acquisitions and non-operating gains, despite mixed segment performance.

Capital raiseThe company intends to refinance its $400 million senior unsecured fixed rate notes due June 1, 2026.The settlement of a significant portion of the mandatorily redeemable noncontrolling interest involved $186.25 million in cash and $18.75 million in Graham Holdings Company Class B common stock.The acquisition of a Honda automotive dealership in October 2025 was financed by borrowing $38.7 million under a delayed draw term loan.
Better than expectedNet income attributable to Graham Holdings Company common stockholders increased by 69.5% for the third quarter of 2025 and 4.4% for the first nine months of 2025 compared to the prior year periods.Diluted earnings per share increased by 70% for the third quarter of 2025 and 5.7% for the first nine months of 2025 compared to the prior year periods.Operating income for the first nine months of 2025 increased by 31% compared to the prior year period, despite a 17.8% decline in the third quarter.Operating revenues showed growth of 6% for the third quarter and 3% for the first nine months of 2025.

Summary

  • Net income attributable to Graham Holdings Company common stockholders for the third quarter of 2025 increased by 69.5% to $122.9 million ($27.91 per share) from $72.5 million ($16.42 per share) in Q3 2024.
  • For the first nine months of 2025, net income attributable to common stockholders rose 4.4% to $183.6 million ($41.75 per share) from $175.8 million ($39.49 per share) in the same period of 2024.
  • Operating revenues for the third quarter of 2025 grew 6% to $1,278.9 million, and for the first nine months, they increased 3% to $3,660.5 million.
  • Operating income for Q3 2025 decreased by 17.8% to $67.1 million, but for the first nine months, it increased by 31% to $187.4 million.
  • The company completed the acquisition of a Honda automotive dealership in October 2025 and two other businesses (education and manufacturing) in 2025 for $19.9 million cash and assumption of $107.4 million in net pension obligations.
  • Graham Holdings settled a significant portion of its mandatorily redeemable noncontrolling interest for $205 million, comprising $186.25 million in cash and $18.75 million in Class B common stock.
  • Cash and cash equivalents decreased by $70.0 million during the first nine months of 2025, primarily due to the noncontrolling interest settlement, capital expenditures, and acquisitions, partially offset by operating cash flow.

Sentiment

Score: 7

Explanation: The company reported strong net income and EPS growth for both the quarter and nine-month periods, driven by significant non-operating gains and revenue growth in key segments like Education, Manufacturing, and Healthcare. While operating income for the quarter declined and some segments (Television Broadcasting, Automotive) faced challenges, the overall financial health, strategic acquisitions, and positive cash flow from operations indicate a generally favorable outlook.

Positives

  • Net income attributable to common stockholders surged 69.5% in Q3 2025 to $122.9 million and increased 4.4% for the first nine months to $183.6 million.
  • Diluted earnings per share significantly improved by 70% in Q3 2025 to $27.91 and by 5.7% for the first nine months to $41.75.
  • Operating revenues increased across the Education (8% in Q3), Manufacturing (30% in Q3), and Healthcare (34% in Q3) segments.
  • The Healthcare segment showed substantial growth in revenue and operating results, driven by CSI's expansion and growth in home health/hospice services.
  • Equity in earnings of affiliates improved significantly, recording a $15.8 million gain in Q3 2025 compared to a $13.4 million loss in Q3 2024, including an $18.6 million gain from the Intersection investment.
  • Net gains on marketable equity securities were $84.8 million in Q3 2025, a substantial increase from $30.5 million in Q3 2024.
  • Net cash provided by operating activities increased to $318.9 million for the first nine months of 2025, up from $290.7 million in the prior year.
  • The company maintains a strong liquidity position with $1,242.9 million in cash, marketable equity securities, and other investments as of September 30, 2025, and $232.8 million available under its revolving credit facility.

Negatives

  • Operating income for the third quarter of 2025 decreased by 17.8% to $67.1 million, primarily due to declines in the Television Broadcasting and Automotive segments.
  • Television Broadcasting revenue declined 28% in Q3 2025 and 16% for the first nine months, mainly due to a $33.4 million decrease in political advertising revenue and lower retransmission and other advertising revenues.
  • Automotive segment operating income decreased by 30% in Q3 2025 and 24% for the first nine months, largely due to lower new and used vehicle sales and gross margins.
  • US Pathways revenues and operating results within Kaplan International were significantly down in Q3 2025 due to changes in US visa policies and practices for international students.
  • The World of Good Brands (WGB) operations were substantially shut down by the end of Q3 2025, incurring asset write-offs and costs.
  • Working capital decreased to $549.3 million at September 30, 2025, from $898.8 million at December 31, 2024.
  • Net cash used in investing activities increased significantly to $98.4 million for the first nine months of 2025, up from $35.7 million in the prior year.

Risks

  • Changes in international laws and regulations, travel restrictions, and related policy announcements could materially adversely affect international student enrollments and Kaplan's business.
  • The emergence of new pandemics and consequential changes to travel and study arrangements could negatively affect Kaplan International and its operating results.
  • Further changes to the regulatory environment, including government policy or practice in oversight and enforcement, war, civil unrest, geopolitical instability, international sanctions, natural disasters, or pandemics, could negatively affect Kaplan's ability to attract and retain students.
  • Increasing imposition of sales taxes on digital services by governments could negatively affect Kaplan International's operating results.
  • Changes to the availability of government funding for education or training, visa policies for students and their dependents, or other administrative immigration requirements could negatively affect Kaplan International's operating results.
  • A trend of tightening student immigration regulations and access to student visas worldwide could impact Kaplan's ability to recruit students.
  • New U.S. presidential administration policies affecting international student entry to, or ability to study in, the U.S., including increased visa vetting and restrictions on conduct, could negatively impact Kaplan's U.S. Pathways business and Kaplan Languages Group.
  • The U.K. government's announced reduction in funding for Level 7 apprenticeships effective in 2026 will impact Kaplan Financial's U.K. apprenticeship business.
  • Macroeconomic risks related to tariff policies and a potential economic slowdown pose a meaningful risk to the company's financial results.

Future Outlook

UK Pathways revenue and operating results are expected to decline in the fourth quarter of 2025 compared to the fourth quarter of 2024 due to timing differences. Retransmission revenue in the television broadcasting division is projected to decrease in 2025 compared to 2024, with this trend expected to continue due to cord-cutting. Clydes Restaurant Group plans to open a new restaurant in Reston, VA, in the second quarter of 2026, and Framebridge intends to open additional retail stores in Q4 2025 and explore further expansion. CSI expects to commence dispensing operations for Pine Drug Holdings, LLC later in Q4 2025. The company estimates capital expenditures for 2025 to be in the range of $80 million to $90 million and plans to refinance its $400 million senior unsecured fixed rate notes due June 1, 2026. Management expects to have sufficient financial resources to meet business requirements for the next 12 months.

Management Comments

  • Management believes the accompanying condensed consolidated financial statements reflect all normal and recurring adjustments necessary for a fair statement of the Company's financial position, results of operations, and cash flows.
  • Management believes there are no existing claims or proceedings that are likely to have a material effect on the Company's business, financial condition, results of operations or cash flows, but it is reasonably possible that future losses could reach approximately $10 million.
  • The Company expects to fund its estimated capital needs primarily through existing cash balances and internally generated funds, and, as needed, from borrowings under its revolving credit facility.
  • In management's opinion, the Company will have sufficient financial resources to meet its business requirements in the next 12 months, including working capital requirements, capital expenditures, interest payments, potential acquisitions and strategic investments, dividends and stock repurchases.

Industry Context

The education segment, particularly Kaplan International, faces headwinds from changes in U.S. visa policies and practices for international students and the tightening of global student immigration regulations. The U.K. government's decision to reduce funding for Level 7 apprenticeships starting in 2026 will impact Kaplan Financial. The Television Broadcasting segment continues to be affected by cord-cutting, leading to declines in retransmission revenue, a trend expected to persist. The automotive segment is experiencing declines in new and used vehicle sales, reflecting broader market dynamics, though services and parts show growth. The healthcare segment, however, is demonstrating significant growth, particularly in infusion treatments and home health/hospice services, indicating strong demand in these areas.

Comparison to Industry Standards

  • NA

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Co-CEOs of Graham Healthcare Group (GHG)David Curtis and Justin DeWitteTo be determinedNADecision to step down from respective leadership roles; will remain for a transition period.
Reporting structure for other healthcare businessesReporting to GHG Co-CEOsReporting directly to Graham Holdings leadershipNARestructuring following Co-CEO departures at GHG.

Legal Proceedings

  • The company and its subsidiaries are subject to complaints and administrative proceedings and are defendants in various civil lawsuits arising in the ordinary course of business.
  • Management believes no existing claims or proceedings are likely to have a material effect on the company's business, financial condition, results of operations, or cash flows.
  • It is reasonably possible that future losses from existing and threatened legal, regulatory, and other proceedings in excess of recorded amounts could reach approximately $10 million.

Related Party Transactions

  • The acquisition of a Honda automotive dealership on October 21, 2025, involves an entity affiliated with Christopher J. Ourisman, a member of the Ourisman Automotive Group family of dealerships.
  • Christopher J. Ourisman and his team of industry professionals operate and manage the company's automotive dealerships, in which the company holds a 90% stake.
  • The company invested an additional $29.3 million in Intersection Holdings, LLC, an equity affiliate, in September 2025. Intersection used a portion of this investment to settle $19.3 million of an outstanding term loan owed to the company.
  • The Chief Executive Officer of Markel Group Inc., Mr. Thomas S. Gayner, is a member of the company's Board of Directors, and the company holds 55,430 shares in Markel Group Inc. valued at $105.9 million as of September 30, 2025.

Stakeholder Impact

  • Shareholders: Positive impact from increased net income and EPS, but potential volatility from segment declines and market risks. The company's stock repurchase authorization provides potential support.
  • Employees: Separation Incentive Programs (SIPs) were offered across various divisions, indicating workforce adjustments. Management changes at Graham Healthcare Group will impact employees in that segment.
  • Customers: Expansion of services in Healthcare (CSI infusion treatments) and new restaurant openings (CRG) benefit customers. Changes in US visa policies and tightening immigration regulations could impact international students at Kaplan.
  • Creditors: The company's debt decreased, and credit ratings were affirmed as Stable by Moodys and Standard & Poor's, indicating a stable credit profile. The intention to refinance notes due in 2026 is a key event for creditors.
  • Suppliers: The acquisition of Arconic Architectural Products by Hoover expands product offerings, potentially impacting suppliers in the manufacturing segment.

Next Steps

  • UK Pathways revenue and operating results are expected to be down in Q4 2025 compared to Q4 2024.
  • CSI expects to commence dispensing operations for Pine Drug Holdings, LLC later in Q4 2025.
  • Framebridge plans to open additional retail stores in Q4 2025 and continues to actively explore other opportunities for further store expansion.
  • Clydes Restaurant Group plans to open a new restaurant in Reston, VA, in Q2 2026.
  • The company intends to refinance its $400 million senior unsecured fixed rate notes due June 1, 2026.
  • The company will continue to assess the fee recorded from Purdue Global on a quarterly basis.
  • The company will continue to track developments and develop plans as needed regarding macroeconomic risks related to tariff policies and a potential economic slowdown.

Key Dates

DateDescription
December 31, 2023Balance sheet date for comparative purposes.
January 2024Company acquired one small business included in other businesses.
March 31, 2024Balance sheet date for comparative purposes.
May 2024Kaplan acquired one small business included in its international division; Company entered into a convertible promissory note agreement to loan N2K Networks $2.0 million.
June 2024World of Good Brands (WGB) completed sales of small businesses.
July 2024Kaplan completed the sale of Red Marker; Clydes Restaurant Group (CRG) opened Rye Street Tavern.
September 30, 2024End of the comparative quarterly and nine-month period.
September 12, 2024Board of Directors authorized the company to acquire up to 500,000 shares of its Class B common stock.
November 2024CRG opened Cordelia Fishbar.
December 2024Company acquired some minority-owned shares of CSI for $2.0 million; Moodys affirmed the company's credit rating and maintained a Stable outlook.
December 15, 2024Effective date for new FASB guidance on enhanced income tax disclosures for annual periods beginning after this date.
December 31, 2024Balance sheet date for comparative purposes.
January 1, 2025New U.S. presidential administration entered office.
February 25, 2025Company and minority shareholders agreed to settle a significant portion of mandatorily redeemable noncontrolling interest for $205 million.
March 31, 2025Balance sheet date for comparative purposes.
April 1, 2024Pension credit retention program no longer offered to new employees at GHG.
April 2025Kaplan completed the sale of BridgeU Limited.
First half of 2025World of Good Brands (WGB) completed the sale of various websites and related businesses.
June 2025Kaplan acquired one small business included in its supplemental education division.
June 12, 2025Standard & Poor's affirmed the company's credit rating and maintained a Stable outlook.
July 4, 2025Legislation known as 'An Act to Provide for Reconciliation Pursuant to Title II of H. Con. Res. 14' (the Act) was enacted in the U.S.
July 15, 2025Hoover acquired Arconic Architectural Products, LLC.
July 2025CSI Pharmacy Holding Company, LLC (CSI) exercised its call option to purchase some minority-owned interest for $1.8 million.
August 2025CSI purchased Pine Drug Holdings, LLC and was issued a California pharmacy license.
Early September 2025Ourisman Jeep of Bethesda dealership ceased operations.
September 2025Company invested an additional $29.3 million in Intersection Holdings, LLC.
September 24, 2025Company executed an amendment to extend the delayed draw term loan availability period to November 10, 2025.
September 30, 2025End of the current quarterly and nine-month period.
October 21, 2025Company's automotive subsidiary acquired a Honda automotive dealership.
October 24, 2025Shares outstanding reported: Class A Common Stock 964,001 Shares, Class B Common Stock 3,398,422 Shares.
October 29, 2025Date of signing for the 10-Q report by CEO and CFO.
November 10, 2025Extended availability period for the delayed draw term loan.
December 2025Outstanding balance on Intersection loan ($5.0 million) repayable by this date; CSI expects dispensing operations for Pine Drug Holdings, LLC to commence later in Q4 2025.
January 31, 2026Promissory note with minority owner for CSI shares due and payable.
March 31, 2026Expected dissolution of GHC One.
June 1, 2026Maturity date for $400.0 million of 5.75% unsecured notes.
December 15, 2026Effective date for new FASB guidance on expense category disclosures for fiscal years beginning after this date.
May 2027All unpaid interest and principal on the N2K Networks convertible promissory note due by this date.
December 15, 2027Effective date for new FASB guidance on internal-use software accounting for fiscal years and interim periods beginning after this date.
March 31, 2029Required dissolution of GHC Two.
December 2041Loan from KIHL to joint venture with University of York repayable by this date.

Recommendation

buy

Graham Holdings Company demonstrates strong financial performance with a significant increase in net income and EPS for both the quarter and year-to-date periods. This is supported by robust revenue growth in key diversified segments such as Education, Manufacturing, and Healthcare, alongside strategic acquisitions that expand its market presence. While there are challenges in the Television Broadcasting and Automotive segments, and some non-operating gains contributed to the bottom line, the overall diversified portfolio, healthy cash flow from operations, and proactive management of its capital structure (including debt reduction and refinancing plans) suggest a resilient and strategically positioned company. The company's substantial marketable securities portfolio also provides a strong liquidity buffer. For a seasoned investor, the current results and strategic direction present a compelling 'buy' opportunity for long-term growth.

Keywords

Diversified Holding Company, Education Services, Television Broadcasting, Manufacturing, Healthcare, Automotive Dealerships, SEC Filing, Quarterly Report, Financial Performance, Earnings Per Share, Revenue Growth, Acquisitions, Risk Factors, Kaplan, Graham Media Group, Graham Healthcare Group, Ourisman Automotive Group

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.